Background illustration for clinical trials search

Prostate Cancer Clinical Trials

Browse 764 prostate cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

for
Prostate Cancer
Location: Omaha NE
Sponsor: University of Nebraska

Sex: Male

Age: 30+

Code: NCT07234981

Phase2, Recruiting

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

for
Prostate Cancer
Location: Omaha NE
Sponsor: University of Nebraska

Sex: Male

Age: 30+

Code: NCT07237269

Phase2, Recruiting

CARE Tool Study Aim 3

for
Gynecologic Cancer, Prostate Cancer, Lung Cancer,
Location: Alton IL, St Louis MO, Rolla MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07296887

Recruiting

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

for
Clinically Significant Prostate Cancer
Location: Chicago IL
Sponsor: Xijing Hospital

Sex: Male

Age: 18+

Code: NCT07492927

Recruiting

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

for
Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 18+

Code: NCT07093177

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase1, Recruiting

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06085729

Phase1, Phase2, Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Lake Success NY, Fairfax VA, Sarasota FL, Detroit MI,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

for
Localized Malignant Solid Neoplasm, Anal Cancer,
Location: Boston MA, Indiana PA, Kernersville NC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07059884

Recruiting

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

for
Metastatic Prostate Cancer, Prostate Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Male

Age: 18+

Code: NCT07145177

Phase1, Recruiting

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (CRPC),
Location: Madison WI
Sponsor: TechnoGenesys, Inc.

Sex: Male

Age: 18+

Code: NCT06705686

Phase1, Recruiting

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

for
Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 20 - 70+

Code: NCT07436078

Recruiting

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

for
Prostate Cancer, High-risk Prostate Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male

Age: 18+

Code: NCT07027124

Phase2, Recruiting

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

for
Prostate Adenocarcinoma, Castration Sensitive Prostate Cancer
Location: Montreal, Hamilton
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Male

Age: 18+

Code: NCT06654336

Phase2, Recruiting

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

for
Prostate Cancer Screening
Location: Toronto, Vancouver
Sponsor: University of Alberta

Sex: Male

Age: 50 - 70

Code: NCT06626022

Phase3, Recruiting

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

for
Metastatic Castration-resistant Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT07142551

Phase2, Recruiting

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

for
Advanced Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT06335914

Recruiting

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

for
Metastatic Breast Cancer, Metastatic Prostate Cancer
Location: Ottawa, Kitchener
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07252726

Recruiting

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

for
Prostatic Neoplasms,
Location: Cleveland OH
Sponsor: Bayer

Sex: Male

Age: 18+

Code: NCT07406282

Recruiting

PSMA PET for Surveillance After Focal Therapy

for
Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis),
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT07115914

Recruiting